Citations

Mayo Clinic

Showing 10 of 108537 citations.

Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management
Johnson, Amanda M. , Ghusn, Wissam , Loftus, Edward V.

Current Opinion in Gastroenterology | April 25, 2024 | Volume: 40 | Issue: 4 | Pages: 268-275

10.1097/mog.0000000000001025 | PMID 38662340 Get It

Purpose of review This review examines the complex relationship between obesity and inflammatory bowel disease (IBD), encompassing their potentially shared pathogenesis, the impact of obesity on the natural history and treatment outcomes of IBD, and the management of obesity in the patient with IBD. Recent findings Obesity represents a state of chronic inflammation that may not only contribute to IBD pathogenesis, but also influence disease progression, complications, and response to treatment. Increased visceral adiposity may carry negative prognostic implications for disease and treatment-specific outcomes. Antiobesity medications, endoscopic bariatric therapies, and even bariatric surgery may be effective and well tolerated in selected patients with IBD. Summary The intersection of obesity and IBD presents a significant clinical challenge, with obesity influencing the natural history of IBD and potentially affecting treatment efficacy. As obesity prevalence among IBD patients rises, a tailored approach to management is crucial, taking into account the individualized risks and benefits of various treatment strategies, including lifestyle interventions, pharmacotherapy, endoscopic procedures, and bariatric surgery.
Reply: Prospective Multicenter Evaluation of Pain Before and After Removal of Nonobstructing Renal Calculi: A CoRE Initiative
Bhojani, Naeem , Wollin, Daniel , Tayeb, Marawan M. El , Scotland, Kymora B. , Knoedler, John, Stern, Karen , Nguyen, David‐Dan , Rivera, Marcelino , Borofsky, Michael S. , Canvasser, Noah, Bechis, Seth K. , Hsi, Ryan S. , Stern, Karen L , Hsi, Ryan

Journal of Urology | April 25, 2024 | Volume: 212 | Issue: 1 | Pages: 232-232

10.1097/ju.0000000000003956 | PMID 38661068 Get It

Machine Learning-Based Prediction Models for Clostridioides difficile Infection: A Systematic Review
Malik, Sheza , Redij, Renisha, Faubion, William A. , Khanna, Sahil , Arunachalam, Shivaram, Tariq, Raseen , Arunachalam, Shivaram P.

Clinical and Translational Gastroenterology | April 25, 2024 | Volume: 15 | Issue: 6 | Pages: e1

10.14309/ctg.0000000000000705 | PMID 38661188 Get It

INTRODUCTION: Despite research efforts, predicting Clostridioides difficile incidence and its outcomes remains challenging. The aim of this systematic review was to evaluate the performance of machine learning (ML) models in predicting C. difficile infection (CDI) incidence and complications using clinical data from electronic health records. METHODS: We conducted a comprehensive search of databases (OVID, Embase, MEDLINE ALL, Web of Science, and Scopus) from inception up to September 2023. Studies employing ML techniques for predicting CDI or its complications were included. The primary outcome was the type and performance of ML models assessed using the area under the receiver operating characteristic curve. RESULTS: Twelve retrospective studies that evaluated CDI incidence and/or outcomes were included. The most commonly used ML models were random forest and gradient boosting. The area under the receiver operating characteristic curve ranged from 0.60 to 0.81 for predicting CDI incidence, 0.59 to 0.80 for recurrence, and 0.64 to 0.88 for predicting complications. Advanced ML models demonstrated similar performance to traditional logistic regression. However, there was notable heterogeneity in defining CDI and the different outcomes, including incidence, recurrence, and complications, and a lack of external validation in most studies. DISCUSSION: ML models show promise in predicting CDI incidence and outcomes. However, the observed heterogeneity in CDI definitions and the lack of real-world validation highlight challenges in clinical implementation. Future research should focus on external validation and the use of standardized definitions across studies.
Complete Percutaneous Coronary Revascularization: An Elegant Solution to Left Ventricular Dysfunction Caused by Severe Coronary Artery Disease
Milutinovic, Stefan , Singh, Kamaldeep, Oluic, Stevan , Mattei, Juan, Escárcega, Ricardo O.

No container title available | April 25, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.171404424.41396169/v1 Get It

Targets and treatments in primary CNS lymphoma
Ferreri, Andrés J.M. , Soussain, Carole , Roemeling, Christina A. Von , Tun, Han W. , Grommes, Christian

Leukemia & Lymphoma | April 25, 2024 | Volume: 65 | Issue: 8 | Pages: 1055-1067

10.1080/10428194.2024.2342560 | PMID 38659230 Get It

Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed
Mitchell, Megan I. , Shi, Miao , Sadoughi, Ali , Shah, Chirag , Siddiqui, T., Okorozo, A. , Gutiérrez, Martín , Unawane, Rashmi , Biamonte, Lisa, Spivack, Simon D. , Loudig, Olivier , Loudig, Olivier , Ben‐Dov, Iddo Z. , Ye, Kenny , Liu, Christina H. , Parikh, Kaushal

Journal of Extracellular Vesicles | April 25, 2024 | Volume: 13 | Issue: 4 | Pages: No page available

10.1002/jev2.12440 | PMID 38659349 Get It

Abstract Lung diseases, including lung cancer, are rising causes of global mortality. Despite novel imaging technologies and the development of biomarker assays, the detection of lung cancer remains a significant challenge. However, the lung communicates directly with the external environment and releases aerosolized droplets during normal tidal respiration, which can be collected, stored and analzsed as exhaled breath condensate (EBC). A few studies have suggested that EBC contains extracellular vesicles (EVs) whose microRNA (miRNA) cargos may be useful for evaluating different lung conditions, but the cellular origin of these EVs remains unknown. In this study, we used nanoparticle tracking, transmission electron microscopy, Western blot analyses and super resolution nanoimaging (ONi) to detect and validate the identity of exhaled EVs (exh‐EVs). Using our customizable antibody‐purification assay, EV‐CATCHER, we initially determined that exh‐EVs can be selectively enriched from EBC using antibodies against three tetraspanins (CD9, CD63 and CD81). Using ONi we also revealed that some exh‐EVs harbour lung‐specific proteins expressed in bronchiolar Clara cells (Clara Cell Secretory Protein [CCSP]) and Alveolar Type II cells (Surfactant protein C [SFTPC]). When conducting miRNA next generation sequencing (NGS) of airway samples collected at five different anatomic levels (i.e., mouth rinse, mouth wash, bronchial brush, bronchoalveolar lavage [BAL] and EBC) from 18 subjects, we determined that miRNA profiles of exh‐EVs clustered closely to those of BAL EVs but not to those of other airway samples. When comparing the miRNA profiles of EVs purified from matched BAL and EBC samples with our three tetraspanins EV‐CATCHER assay, we captured significant miRNA expression differences associated with smoking, asthma and lung tumor status of our subjects, which were also reproducibly detected in EVs selectively purified with our anti‐CCSP/SFTPC EV‐CATCHER assay from the same samples, but that confirmed their lung tissue origin. Our findings underscore that enriching exh‐EV subpopulations from EBC allows non‐invasive sampling of EVs produced by lung tissues.
Filamin C-Associated Nemaline Myopathy
Shammas, Ibrahim , Alhammad, Reem , Naddaf, Elie , Naddaf, Elie

Neurology | April 24, 2024 | Volume: 102 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000209477 | PMID 38657199 Get It

Severe Hypertriglyceridemia in a Patient With Metabolic Syndrome and Psoriasis on Risankizumab-Rzaa
Abdulwadood, Isra , melo, Jose F De, Scheel, Robert , Bois, John P. , De Melo, Jose F, Scheel, Robert C, Melo, Jose F de , Scheel, Robb

JCEM Case Reports | April 24, 2024 | Volume: 2 | Issue: 6 | Pages: No page available

10.1210/jcemcr/luae087 | PMID 38911361 Get It

Abstract We report a case of severe hypertriglyceridemia (HTG) complicated by hyperviscosity syndrome as a possible adverse reaction to risankizumab-rzaa in a 49-year-old male with a history of longstanding uncontrolled type 2 diabetes, obesity, and coronary artery disease with prior ST-elevation myocardial infarction. On admission, the patient presented with xanthomatous plaques, chest and epigastric discomfort, and headache. Subsequent blood testing revealed severely elevated triglyceride (TG) levels at 7670 mg/dL (86.59 mmol/L) [reference range: <150 mg/dL; 1.69 mmol/L] and total cholesterol at 934 mg/dL (24.14 mmol/L) [reference range: <200 mg/dL; 5.17 mmol/L]. Triglyceride levels decreased and symptoms resolved with dietary restrictions and plasmapheresis. At follow-up, his TG remained elevated but improved, and he was advised to continue lipid-lowering medications as well as cessation of risankizumab. While the patient presented with high risk factors, we posit that the subacute presentation of severe HTG is a possible result of his recent course of risankizumab-rzaa therapy for management of psoriasis. This is noteworthy as pharmaceutical surveys and clinical trials do not list severe HTG as an adverse effect. Postmarketing surveillance studies are essential to confirm this potential association and monitor drug safety. In summary, this case highlights a possible link between risankizumab and severe HTG, emphasizing the importance of ongoing pharmacovigilance to identify and manage unexpected adverse effects associated with new medications.
Ultrasound Shear Wave Elastography for Noninvasive Diagnosis of Acute Compartment Syndrome Using a Novel In Vivo Turkey Model
Tsukamoto, Ichiro , Iida, Naoya , Yousefi, Farbod , Adam, Elameen, Selim, Omar , Zhao, Gongyin , Wan, Rou , Sarcon, Aida K. , Zhao, Chunfeng , Selim, Omar , Sarcon, Aida, Selim, Omar A

Military Medicine | April 24, 2024 | Volume: 189 | Issue: Supplement_3 | Pages: 644-651

10.1093/milmed/usae211 | PMID 39160890 Get It

ABSTRACT Introduction Acute Compartment Syndrome (ACS) is a severe trauma caused by elevated intra-muscle-compartment pressure (ICP). The current standard method for diagnosis is to insert a needle into the muscle sterilely under anesthesia. However, to secure the environment is sometimes not easy and leads to delays in diagnosis. Recently, we have focused on shear wave ultrasound elastography (SWE) as an alternative, which can be done concisely in unclean environment and without anesthesia. We would like to report the usefulness of SWE for ACS diagnosis using 2-pedal walking turkey model recently developed in our lab. Materials and Methods A total of 32 1-year-old Bourbon turkeys were used. 5% solution of chicken albumin was infused continuously into the tibialis cranialis (TC) muscle using IV pump. The ICP was increased stepwise from 0 to 50 mmHg. During the rising of ICP, the correlation between values of SWE (kPa) and ICP (mmHg) was measured. After the ICP reached 50 mmHg, half of the turkeys were maintained at this pressure for 2 hours and the rest for 6 hours. After infusion, a fasciotomy was performed on the half turkey. Half of the turkeys were euthanized after 2 weeks and the rest after 6 weeks. SWE of TC muscle and walking gait data on turkeys using a portable walkway system were measured weekly until euthanasia. At euthanasia, isometric tetanic muscle force (ITF) tests to TC muscle and histological evaluations were performed. Results SWE value (kPa) was highly significantly correlated to the actual ICP (mmHg) (R2 = 0.91). Stance of ACS side leg were significantly extended, and swing of the control side shortened from the second to the third week after ACS in the 6 hours infusion-no-fasciotomy group (P < 0.05*). ITF was significantly reduced mainly in the 6 hours infusion group (P < 0.05*). Histological evaluation revealed that in the 6 hours infusion and 6 weeks survival group, both the muscle fiber and intercellular distances were significantly expanded (P < 0.05). Conclusion SWE seems to be a substitute measure of ICP in diagnosing ACS. With regard to our in vivo ACS model using turkey, survival at 50 mmHg ICP for 6 hours and 6 weeks post ACS would be an appropriate situation.
Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?
Kashani, Kianoush , Kashani, Kianoush B , Suppadungsuk, Supawadee

Clinical Chemistry | April 24, 2024 | Volume: 70 | Issue: 7 | Pages: 894-896

10.1093/clinchem/hvae010 | PMID 38656315 Get It